Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells

被引:141
作者
Marshall, JS [1 ]
LealBerumen, I [1 ]
Nielsen, L [1 ]
Glibetic, M [1 ]
Jordana, M [1 ]
机构
[1] MCMASTER UNIV,INTESTINAL DIS RES PROGRAMME,HLTH SCI CTR,HAMILTON,ON L8N 3Z5,CANADA
关键词
mast cells; IL-10; IL-6; TNF-alpha; inflammation;
D O I
10.1172/JCI118506
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mast cells have been implicated in a number of diseases involving chronic inflammation including asthma, rheumatoid arthritis, and inflammatory bowel diseases. They are a potent source of several cytokines, including IL-6 and TNF-alpha. Freshly isolated rat peritoneal mast cells will produce IL-6 in response to anti-IgE, LPS, PGE(1), or PGE(2); however, the mechanisms by which such cytokine production is regulated are poorly understood. IL-10 is recognized as an important immunoregulatory cytokine with effects on T cell development and the production of inflammatory cytokines. IL-10 has previously been described to enhance mast cell development in the context of IL-3 and IL-4. In the current study, we have examined the ability of IL-10 to modulate rat peritoneal mast cell IL-6 and TNF-alpha production in response to a variety of stimuli. We have observed that recombinant murine IL-10 can inhibit the production of both IL-6 and TNF-alpha by mast cells without altering the degree of histamine release in response to anti-IgE. Concentrations of IL-10 as low as 0.2 ng/ml were sufficient to inhibit IL-6 production by LPS- or anti-IgE-activated cells significantly. IL-10 also inhibited PGE(1)- and PGE(2)-induced IL-6 production. The relative potency of IL-10 as an inhibitor of mast cell IL-6 production was highly dependent upon the stimulus used, with a 10-fold difference in the IC50 for LPS- or anti-IgE-activated cells (0.21 ng/ml) and cells activated with a combination of LPS and PGE, (2.29 ng/ml). This suggests that prostanoids may limit the ability of IL-10 to modulate mast cell IL-6 production in the context of inflammation. These data have important implications for the regulation of mast cell IL-6 in inflammatory diseases involving prostanoid production and the effects of treatment with cyclooxygenase inhibitors. Our results also demonstrate a dual role for IL-10 on mast cells as a growth factor and inhibitor of cytokine production.
引用
收藏
页码:1122 / 1128
页数:7
相关论文
共 45 条
  • [21] INTERLEUKIN-10 PROTECTS MICE FROM LETHAL ENDOTOXEMIA
    HOWARD, M
    MUCHAMUEL, T
    ANDRADE, S
    MENON, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) : 1205 - 1208
  • [22] ELEVATED BRONCHOALVEOLAR LAVAGE FLUID HISTAMINE LEVELS IN ALLERGIC ASTHMATICS ARE ASSOCIATED WITH INCREASED AIRWAY-OBSTRUCTION
    JARJOUR, NN
    CALHOUN, WJ
    SCHWARTZ, LB
    BUSSE, WW
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (01): : 83 - 87
  • [23] KASAMA T, 1994, J IMMUNOL, V152, P3559
  • [24] INTERLEUKIN-10-DEFICIENT MICE DEVELOP CHRONIC ENTEROCOLITIS
    KUHN, R
    LOHLER, J
    RENNICK, D
    RAJEWSKY, K
    MULLER, W
    [J]. CELL, 1993, 75 (02) : 263 - 274
  • [25] LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468
  • [26] LEALBERUMEN I, 1995, J IMMUNOL, V154, P4759
  • [27] MALEFYT RD, 1991, J EXP MED, V174, P1209
  • [28] LEUKEMIA INHIBITORY FACTOR PRODUCTION BY RAT MAST-CELLS
    MARSHALL, JS
    GAULDIE, J
    NIELSEN, L
    BIENENSTOCK, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) : 2116 - 2120
  • [29] MOLLER A, 1993, J IMMUNOL, V151, P3261
  • [30] NILSSON G, 1994, IMMUNOLOGY, V81, P73